Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004623570 | SCV005116015 | uncertain significance | Cardiovascular phenotype | 2024-04-26 | criteria provided, single submitter | clinical testing | The p.I199L variant (also known as c.595A>T), located in coding exon 4 of the FKBP14 gene, results from an A to T substitution at nucleotide position 595. The isoleucine at codon 199 is replaced by leucine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. |